SUBSCRIBE NOW AND SAVE 3 months just 99 ¢/month

ADVERTISEMENT

ADVERTISEMENT

Minnesota COVID hospitalizations remain high; weekly case rate drops

State reports 32 deaths, 6,122 new cases.

fusion-medical-animation-EAgGqOiDDMg-unsplash.jpg
Photo: Unsplash/Fusion Medical Animation

ST. PAUL — Minnesota remains at a record level of hospitalizations for COVID-19 in 2021, according to numbers released Monday, Dec. 6, by the state department of health, though the seven-day rolling average of new cases per 100,000 continued to drop.

Following are the Minnesota Department of Health COVID-19 case rates, deaths, hospitalizations and vaccinations as of Monday. Because all data is preliminary, some numbers and totals may change from one day to the next.

Statewide case rates

  • NEW CASES: 6,122
  • SEVEN-DAY, ROLLING AVERAGE OF NEW CASES PER 100,000 PEOPLE: 61.9 (as of 11/26)

  • TOTAL CASES, INCLUDING REINFECTIONS: 933,025
  • TOTAL REINFECTIONS: 10,747
  • SEVEN-DAY, ROLLING AVERAGE TEST POSITIVITY RATE: 10.4% (as of 11/26)

Hospitalizations, deaths

  • ACTIVE HOSPITALIZATIONS: 1,570

  • TOTAL HOSPITALIZATIONS: 46,863

  • DEATHS, NEWLY REPORTED: 38

  • TOTAL DEATHS: 9,654

Vaccinations

  • FIRST DOSE ADMINISTERED: 3,667,362 or 70.4% of ages 5 and up

  • COMPLETED SERIES (2 doses): 3,392,658 or 65.1% of ages 5 and up

  • BOOSTER DOSES ADMINISTERED: 1,211,323

As a public service, we’ve opened this article to everyone regardless of subscription status. If this coverage is important to you, please consider supporting local journalism by clicking on the subscribe button in the upper righthand corner of the homepage.

What to read next
What do your eyes have to do with heart disease? In this episode of NewMD's "Health Fusion," Viv Williams explains how a trip to the optometrist could help predict your risk of heart attack, thanks to AI technology.
A recent surge in cases may have reached its peak statewide, though hospitalizations and new cases remain high.
Men who worry may be at increased of getting heart disease younger. In this episode of NewsMD's "Health Fusion," Viv Williams has details of a new study about the potential negative effects of worrying.
The ACTIV-6 clinical trial will include the study of fluticasone, fluvoxamine and ivermectin to treat mild to moderate COVID infection.